Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Insmed introduces new prostacyclin analogues

May 14, 2015

Merck & Co. discloses ROM-K channel blockers

May 13, 2015

Roche patents CYP11B2 inhibitors

May 13, 2015

FDA gives Brilinta priority review for prevention of post-MI cardiovascular events

April 29, 2015

CUPID2 trial of Mydicar fails to meet endpoints

April 27, 2015

scPharmaceuticals initiates pivotal trial of furosemide solution for subcutaneous administration

April 22, 2015

FDA approves Amgen's ivabradine for chronic heart failure

April 16, 2015

FDA advisory committee recommends approval of cangrelor for use in PCI

April 16, 2015

Vectus Biosystems patents novel compounds for hypertension and fibrosis

April 15, 2015

Bayer Schering Pharma discloses CCR2 antagonists

April 15, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...